Levalbuterol HCL Solution
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D221R0116
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is procuring Levalbuterol HCL Solution, a pharmaceutical preparation used for respiratory treatment, through solicitation SPE2D2-21-R-0116. The original solicitation was posted on February 3, 2022, and underwent five amendments that extended the closing date multiple times from the initial March 7, 2022 deadline to the final April 18, 2022 due date. Amendment 0001 clarified the unit description by adding "milligrams" to the specification, while Amendment 0003 added packaging requirements specifying 30 count vials per case and included additional solicitation pages as attachments. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC code 6505 for Drugs and Biologicals. The multiple deadline extensions suggest the agency encountered challenges in the procurement process or needed additional time to refine requirements.
This solicitation does not utilize any set-aside designations, making it open to all qualified contractors. Based on the contract modification documents, Teva Pharmaceuticals USA, Inc. was awarded the resulting contract SPE2D2-22-D-0146, with the government subsequently exercising option years in 2024 and 2025. The most recent modification shows the contract extending through August 30, 2026, indicating this is a multi-year contract with option periods that the government has found valuable enough to continue exercising. The contract appears to be administered by DLA Troop Support Medical Supply Chain in Philadelphia, PA, which serves as the primary location for contract management and oversight. The successful procurement demonstrates the government's ongoing need for this respiratory medication through its medical supply chain operations.
Notice text
8 versions
Update #8 · Latest ·
Modification exercising of 3rd year option.
Update #7 ·
Modification to accounce exercising of 2nd year option.
Update #6 ·
Amendment 0005 is issued to extend the closing date from April 04, 2022 to April 18, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0004 is issued to extend the closing date from March 21, 2022 to April 04, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment.
Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description.
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
Update #5 ·
Amendment 0004 is issued to extend the closing date from March 21, 2022 to April 04, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment.
Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description.
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
Update #4 ·
Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment.
Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description.
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
Update #3 ·
Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description.
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
Update #2 ·
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution,
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
Update #1 ·
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Levalbuterol HCL Solution | Award Notice | |
| This notice | Solicitation | |
| Levalbuterol HCL Solution | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| TUBE,INHALER and 4 more items | Medical Supply Chain | No set-aside | |
| LIDOCAINE HYDROCHLORI and 3 more items | Medical Supply Chain | No set-aside | |
| Nebulizer,portable | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity